What’s The Short Term Opportunity In This  Pharmaceutical Company: Avenue Therapeutics Inc. (NASDAQ: ATXI )

What’s The Short Term Opportunity In This Pharmaceutical Company: Avenue Therapeutics Inc. (NASDAQ: ATXI )

Avenue Therapeutics Inc. (NASDAQ: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.

One Technology Stock to Punt On (NYSE: FSLY)

One Technology Stock to Punt On (NYSE: FSLY)

Fastly Inc. (NYSE: FSLY) operates a content delivery network (CDN), which is necessary for entities to provide faster and more reliable online content. Fastly’s strategy differs from traditional CDNs, which focused on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly is far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated about two thirds of its revenue in the United States in 2020.

How Is the Needle Moving On This Biodiesel Producer: Renewable Energy Group Inc (NASDAQ: REGI)

How Is the Needle Moving On This Biodiesel Producer: Renewable Energy Group Inc (NASDAQ: REGI)

Renewable Energy Group Inc (NASDAQ: REGI) is leading the transformation of biofuel into something that helps improve the environment and grow customers’ profits by delivering cleaner fuels to meet growing global demand.

This short-term pessimism can be a blessing in disguise for long-term investors: Meta Platforms Inc (NASDAQ: FB )

This short-term pessimism can be a blessing in disguise for long-term investors: Meta Platforms Inc (NASDAQ: FB )

Meta Platforms Inc. (NASDAQ: FB) is the world’s largest online social network, with 2.5 billion monthly active users. Users engage with each other in different ways, exchanging messages and sharing news events, photos, and videos. On the video side, the firm is in the process of building a library of premium content and monetizing it via ads or subscription revenue. Meta refers to this as Facebook Watch. The firm’s ecosystem consists mainly of the Facebook app, Instagram, Messenger, WhatsApp, and many features surrounding these products. Users can access Facebook on mobile devices and desktops. Advertising revenue represents more than 90% of the firm’s total revenue, with 50% coming from the U.S. and Canada and 25% from Europe. With gross margins above 80%, Meta operates at a 30%-plus margin.

Shall You Invest In This Small Cap Energy Company Amidst The Current War Situation: Pedevco Corp (NYSEAMERICAN: PED)
|

Shall You Invest In This Small Cap Energy Company Amidst The Current War Situation: Pedevco Corp (NYSEAMERICAN: PED)

PEDEVCO Corp (NYSEAMERICAN: PED) is an energy company. It is engaged in the acquisition, exploration, development, and production of oil and natural gas shale plays in the Denver-Julesberg Basin (D-J Basin) in Colorado. The D-J Basin contains hydrocarbon-bearing deposits in several formations, including the Niobrara, Codell, Greenhorn, Shannon, J-Sand, and D-Sand. Its principal operating properties are in the Wattenberg, Wattenberg Extension and Niobrara formation in the D-J Basin.

Is It A Good Time To Buy This Social Media Giant: Snap Inc. (NYSE: SNAP)

Is It A Good Time To Buy This Social Media Giant: Snap Inc. (NYSE: SNAP)

Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.

What’s the long term Investment Opportunity in this Lithium Producer: Lithium Americas Corp ( TSE:LAC)
|

What’s the long term Investment Opportunity in this Lithium Producer: Lithium Americas Corp ( TSE:LAC)

Lithium Americas (TSE: LAC) is developing three lithium production assets, two brine resources located in northwestern Argentina and a clay resource in Nevada, U.S. While the company has no current lithium production, company expects the first Argentina resource, Cauchari-Olaroz, to enter production in late 2022. Lithium Americas plans for all three resources to be fully integrated, selling into the lithium chemical market.

An Oversold Tech Stock Worth a Look: Datadog Inc (NASDAQ: DDOG)

An Oversold Tech Stock Worth a Look: Datadog Inc (NASDAQ: DDOG)

Datadog is a cloud-native company that focuses on analyzing machine data. The firm’s product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog’s platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses

How Undervalued Is This EV Charging Solution Company: Tritium Dcfc Ltd (NASDAQ: DCFC)

How Undervalued Is This EV Charging Solution Company: Tritium Dcfc Ltd (NASDAQ: DCFC)

Tritium DCFC Ltd, founded in 2001 by e-mobility pioneers designs and manufactures proprietary hardware and software to create advanced and reliable DC fast chargers for electric vehicles. Tritium global developer and manufacturer of direct current (DC) fast chargers for electric vehicles (EVs), Company has marked its presence in 41 countries with more than 6500 chargers sold so far and growing at a higher pace than its competitors

How is the needle moving on this healthcare Stock:BioDelivery Sciences International, Inc.(NASDAQ: BDSI)

How is the needle moving on this healthcare Stock:BioDelivery Sciences International, Inc.(NASDAQ: BDSI)

BioDelivery Sciences International Inc (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.